R & D- medical: biomedical (applied research/exploratory development)
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN268201600013C
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,414,353
Award facts
- Opportunity
-
- HHSNIHNHLBICSBHL201613NIR Solicitation number
- HHS-NIH-NHLBI-CSB-HL-2016-13-NIR Science Moving towArds Research Translation and Therapy (SMARTT), Non-Biologics & Small Molecules Production Facility (PF) Program Extension (Follow-on) (Sole Source) Award Notice · Posted Jan 27, 2015
- Contract value 100% obligated
- $3,414,353.36 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Funding Only Action | $17,642 | |
| Change Order | -$111,767 | |
| Funding Only Action | $92,351 | |
| Exercise an Option | $965,181 | |
| Funding Only Action | $165,445 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,110,432 | |
| Original award | $1,175,069 |
About this award
This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to SRI International, a non-profit research and development institute. The $3,414,353.36 cost-plus-fixed-fee contract is for the "SMARTT NON-BIOLOGICS AND SMALL MOLECULE PRODUCTION FACILITY" program, which involves applied research and exploratory development in biomedical R&D. The contract has a completion date of September 7, 2023 and was initially awarded on March 1, 2016. SRI International has subcontracted portions of the work to Ambiopharm, Inc. and Shanghai Chempartner Co., LTD. The contract is not designated as a small business set-aside. SRI International has a strong history of federal contract and grant awards across diverse scientific and technical domains, serving as a key partner to numerous government agencies.
Quick answers
Who was awarded contract HHSN268201600013C?
HHSN268201600013C was awarded to Sri International by National Heart Lung and Blood Institute (National Institutes of Health) on March 1, 2016.
How much is contract HHSN268201600013C worth?
The government has obligated $3,414,353 on HHSN268201600013C.
Was contract HHSN268201600013C competed?
The extent of competition for HHSN268201600013C was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award